Polynovo WKN: A12F4T ISIN: AU000000PNV0 Kürzel: CALZF Branche: Gesundheit, Medizinische, Instrumente, Zubehör
bin jetzt auch mit an Board 👍
|
|
Themen zum Wert | ||
|---|---|---|---|
| 1 | CALZADA Hauptdiskussion |
Kursdetails
| Geld (bid) | 1,26 (367) |
|---|---|
| Brief (ask/offer) | 1,32 (367) |
| Spread | 4,55 |
| Geh. Stück | 0 |
| Eröffnung | 1,27 |
| Vortag | 1,24 |
| Tageshoch | 1,29 |
| Tagestief | 1,27 |
| 52W Hoch | 1,54 |
| 52W Tief | 0,74 |
Tagesvolumen
| in EUR gehandelt | 0 Stk |
|---|---|
| in USD gehandelt | 1.000 Stk |
| in CHF gehandelt | 0 Stk |
| in AUD gehandelt | 0 Stk |
| Gesamt | 1.000 Stk |
Partner-News
Anzeige9:45 Uhr • Partner • Societe Generale
8:50 Uhr • Partner • Societe Generale
7:30 Uhr • Partner • BNP Paribas
6:45 Uhr • Partner • BNP Paribas
6:35 Uhr • Partner • BNP Paribas
Aktien-News
9:48 Uhr • Artikel • dpa-AFX
9:35 Uhr • Artikel • dpa-AFX
9:30 Uhr • Meldungen • EQS News
Geld/Brief Kurse
Neu laden| Börse | Geld | Vol. | Brief | Vol. | Zeit | Vol. ges. | Kurs |
|---|---|---|---|---|---|---|---|
| L&S Exchange | 1,26 | 367 Stk | 1,32 | 367 Stk | 1713945185 09:53 | 1,29 EUR | |
| Nasdaq OTC | 1713917400 02:10 | 1.000 Stk | 1,35 USD | ||||
| Baader Bank | 1,26 | 3.125 Stk | 1,30 | 3.125 Stk | 1713939157 08:12 | 1,28 EUR | |
| Frankfurt | 1,25 | 6.000 Stk | 1,33 | 5.700 Stk | 1713939578 08:19 | 1,25 EUR | |
| Tradegate | 1,25 | 2.417 Stk | 1,32 | 2.271 Stk | 1713904005 23. Apr | 1,24 EUR | |
| Lang & Schwarz | 1,26 | 367 Stk | 1,32 | 367 Stk | 1713945170 09:52 | 1,29 EUR | |
| TTMzero RT | 1713939579 08:19 | 1,28 EUR | |||||
| Düsseldorf | 1,24 | 3.000 Stk | 1,33 | 3.000 Stk | 1713943838 09:30 | 1,24 EUR | |
| München | 1,26 | 3.500 Stk | 1,30 | 3.500 Stk | 1713939145 08:12 | 1,26 EUR | |
| Stuttgart | 1,26 | 20.000 Stk | 1,31 | 20.000 Stk | 1713939464 08:17 | 1,26 EUR | |
| BX Swiss | 1,23 | 8.719 Stk | 1,29 | 8.719 Stk | 1713886057 23. Apr | 1,18 CHF | |
| Sydney | 1713853494 23. Apr | 2,04 AUD | |||||
| Gettex | 1,26 | 3.125 Stk | 1,30 | 3.125 Stk | 1713944587 09:43 | 1,26 EUR | ges. 1.000 Stk |
Börsennotierung
| Marktkapitalisierung in EUR |
|---|
| 852,4 Mio. |
| Anzahl der Aktien |
| 690,2 Mio. |
Termine
| 21.08.2024 | Quartalsmitteilung |
|---|---|
| 02/25 | Quartalsmitteilung |
Grundlegende Daten zur POLYNOVO LTD Aktie
| Finanzdaten | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
|---|---|---|---|---|---|---|---|
| KUV | 91,95 | 66,50 | 24,23 | 22,60 | - | - | - |
| Ergebnis je Aktie (bereinigt) | -0,01 | -0,01 | -0,002 | -0,01 | 0,01 | - | - |
| Cashflow | -0,4 Mio. | -0,2 Mio. | -2,1 Mio. | -5,9 Mio. | - | - | - |
| Eigenkapitalquote | 62,90 % | 58,30 % | 50,66 % | 70,59 % | - | - | - |
| Verschuldungsgrad | 58,98 | 71,52 | 97,41 | 41,66 | - | - | - |
| EBIT | -4,1 Mio. | -4,2 Mio. | -0,3 Mio. | -6,2 Mio. | - | - | - |
| Fundamentaldaten | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
| KCV | -2.758,50 | -6.650,00 | -484,53 | -203,40 | - | - | - |
| Kurs-Gewinn-Verhältnis (KGV) | -275,85 | -266,00 | -726,80 | -203,40 | 224,39 | - | - |
| Bilanzdaten | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
| Umsatzerlöse | 22,2 Mio. | 29,2 Mio. | 41,4 Mio. | 65,2 Mio. | - | - | - |
| Ergebnis vor Steuern | -4,2 Mio. | -4,6 Mio. | -1,2 Mio. | -4,9 Mio. | - | - | - |
| Steuern | 29.685 | 54.628 | 41.608 | -8.559 | - | - | - |
Info POLYNOVO LTD Aktie
Polynovo
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell Implant to host pancreatic islet cells in the skin; NovoSorb MTX for the treatment of varying complex wounds; and plastics and reconstructive device product. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.